Trial intelligence / Profile preview

Plerixafor Rescue Mobilization in Stem Cell Transplant

NCT00901225Phase 2Completed

Sponsor
Duke University
Start
May 2009
Primary completion
Aug 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of plerixafor in multiple myeloma (MM), non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), sponsored by Duke University. Started May 2009; status: completed.

02

Drugs

plerixafor
03

Conditions

multiple myeloma (MM)non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)

Beyond the preview

Go deeper on NCT00901225.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00901225.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call